🇸🇬 Padcev Ejfv in Singapore

Padcev Ejfv (enfortumab-vedotin) regulatory status in Singapore.

Marketing authorisation

HSA

  • Status: likely_approved

Padcev Ejfv in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Oncology approved in Singapore

Frequently asked questions

Is Padcev Ejfv approved in Singapore?

Yes. HSA has authorised it.

Who is the marketing authorisation holder for Padcev Ejfv in Singapore?

Astellas Pharma is the originator. The local marketing authorisation holder may differ — check the official source linked above.